ATRASENTAN HYDROCHLORIDE | N219208 | NOVARTIS PHARMACEUTICALS CORP
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8623819 | Aug 22, 2028 | — | — | — | — | |
| 9364458 | Jul 7, 2034 | — | — | Yes | — | |
| 10016393 | Jul 7, 2034 | — | — | Yes | — | — |
| 11491137 | Dec 16, 2040 | — | — | — | — | |
| 11874283 | Feb 18, 2032 | — | — | — | — | |
| 11998526 | Dec 16, 2040 | — | — | — | — | |
| 12121509 | Dec 16, 2040 | — | — | — | — | |
| 12370174 | Dec 16, 2040 | — | — | — | — | |
| 12521369 | Feb 23, 2041 | — | — | — | — | |
| 12582631 | Mar 25, 2043 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | Apr 2, 2030 | Active |